Lawrence Corey

Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division

SCHOLARLY PAPERS

7

DOWNLOADS

515

TOTAL CITATIONS

0

Scholarly Papers (7)

1.

Risk of COVID-19 after Natural Infection or Vaccination

Number of pages: 24 Posted: 01 May 2023
University of Pittsburgh - Department of Pediatrics, University of Maryland - Department of Pediatrics, Fred Hutchinson Cancer Research Center, affiliation not provided to SSRN, Fred Hutchinson Cancer Research Center, University of California, San Diego (UCSD) - Division of Infectious Diseases and Global Public Health, University of South Florida - Morsani College of Medicine, Emory University School of Medicine and Children’s Healthcare of Atlanta - Department of Pediatrics, Ndlovu Research Centre, Harvard University - Brigham and Women’s Hospital, Baylor College of Medicine, Instituto Nacional de Infectologia Evandro Chagas, Fiocruz - Lab. De Pesquisa Clinica DST/AIDS, South African Medical Research Council, University of North Carolina (UNC) at Chapel Hill - School of Medicine, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Moderna, Inc., AstraZeneca Pharmaceuticals, Janssen Research & Development, LLC, Novavax, Inc., University of Maryland - Center for Vaccine Development and Global Health, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of Alabama at Birmingham - Heersink School of Medicine, Harvard University - Brigham and Women’s Hospital, Government of the United States of America - Biostatistics Research Branch and University of Maryland - Department of Pediatrics
Downloads 199 (313,063)

Abstract:

Loading...

COVID-19, natural infection, hybrid immunity, vaccination

2.

Hybrid Versus Vaccine Immunity of mRNA-1273 Among People Living with HIV in East and Southern Africa: The Multicentre, Open-Label COVPN 3008 (Ubuntu) Clinical Trial

Number of pages: 32 Posted: 11 Jul 2024
Centre for the AIDS Programme of Research in Africa (CAPRISA), University of KwaZulu- Natal, University of Washington, Fred Hutchinson Cancer Research Center, Johns Hopkins Bloomberg School of Public Health, Malawi, Fred Hutchinson Cancer Research Center, University of Zimbabwe, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Duke University - Department of Surgery, Fred Hutchinson Cancer Research Center, Chris Hani Baragwanath Academic Hospital, KwaZulu-Natal Research Innovation and Sequencing Platform - KRISP, University of KwaZulu-Natal, University of KwaZulu-Natal - School of Laboratory Medicine and Medical Sciences, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, National Institutes of Health, National Institutes of Health, COVID-19 Prevention Network, University of Zimbabwe - Faculty of Medicine and Health Sciences, Baylor College of Medicine, Botswana Harvard AIDS Institute Partnership (BHP), Centre for Infectious Disease Research in Zambia, Columbia University - ICAP, Wits University - Clinical HIV Research Unit, Aurum Institute, Synexus Helderberg, University of Cape Town Lung Institute, University of the Witwatersrand - Reproductive Health and HIV Research Unit (RHRU), TASK, FAMCRU Family Clinical Research Unit, University of Cape Town (UCT), Aurum Institute, University of North Carolina (UNC) at Chapel Hill - UNC-Project Malawi, Center for Family Health Research Zambia (CFHRZ), The Aurum Institute, Aurum Institute, South African Medical Research Council, UNC Global Projects, Soweto Clinical Trials Centre, Blantyre District Council, Center for Family Health Research Zambia (CFHRZ), Wits Health Consortium - Perinatal HIV Research Unit (PHRU), Synergy Biomed Research Institute, MERC Middelburg, Kisumu Clinical Research Site, TASK, TASK, Tembisa Clinic 4, Nelson Mandela Academic Clinical Research Unit Clinical Research Site, University of the Witwatersrand - Perinatal HIV Research Unit, Joint Clinical Research Centre, University of KwaZulu-Natal, South African Medical Research Council, Soweto Clinical Trials Centre, UVRI-IAVI HIV Vaccine Program, MeCRU Clinical Research Site, Maseno University, Synexus Stanza Clinical Research Centre Clinical Research Site, University of KwaZulu-Natal, PHOENIX Pharma (Pty) Ltd, Moi University, University of Cape Town (UCT), MERC Kempton, MERC Welkom, MU-JHU Care Ltd - MUJHU Research Collaboration, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, University of Cape Town (UCT) - Desmond Tutu HIV Foundation, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, South African Medical Research Council, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Qhakaza Mbokodo Research Clinic and Independent
Downloads 107 (520,619)

Abstract:

Loading...

People living with HIV, SARS-CoV-2, mRNA-1273, hybrid immunity, vaccine immunity, COVID-19

3.

Lower SARS-CoV-2-Specific Humoral Immunity in People Living With HIV-1 Recovered From Symptomatic Non-Hospitalized COVID-19

Number of pages: 44 Posted: 04 Jan 2022
affiliation not provided to SSRN, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Duke University - School of Medicine, affiliation not provided to SSRN, Fred Hutchinson Cancer Research Center, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University, affiliation not provided to SSRN, Duke University - Duke Human Vaccine Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of Pennsylvania - Department of Medicine, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology and affiliation not provided to SSRN
Downloads 64 (703,999)

Abstract:

Loading...

HIV-1, PLWH, People Living with HIV, SARS-CoV-2, COVID-19, humoral immunity, antibody, antibody isotype, antibody subclass, ACE-2 blocking, ADCP, antibody dependent phagocytosis, Multiplex assay, Meso Scale Discovery, IgG, IgG1, IgG3, IgA, CoVPN

4.

Pharmacokinetic Serum Concentrations of VRC01 Correlate with Prevention of HIV-1 Acquisition

Number of pages: 35 Posted: 18 Oct 2022
Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Duke University, Duke University - School of Medicine, Duke University - School of Medicine, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Independent, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of Washington, University of Cape Town (UCT) - Institute of Infectious Disease and Molecular Medicine, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of Washington - Department of Biostatistics, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Government of the United States of America - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Family Health International, Via Libre CRS, University of California, Los Angeles (UCLA) - Department of Medicine, Wits Health Consortium - Perinatal HIV Research Unit (PHRU), University of Cape Town (UCT) - Department of Medicine, University of Pennsylvania, Asociacion Civil Impacta Salud y Educacion, Emory University - School of Medicine, San Miguel Clinical Research Center - Asociacion Civil Impacta Salud y Educacion, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, National Institute for Communicable Diseases of the National Health Laboratory Service, Duke University - Duke Human Vaccine Institute, University of North Carolina (UNC) at Chapel Hill - Department of Medicine, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division and Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology
Downloads 56 (750,322)

Abstract:

Loading...

body weight, HIV, prevention, broadly neutralizing antibodies, monoclonal antibody, pharmacokinetics

5.

SARS-CoV-2 Variant is Strongly Associated with Peak Viral Load and Shedding Duration with Minimal Impact from Host Factors: Results from the CoVPN 5001 Study

Number of pages: 25 Posted: 11 Nov 2024
University of Washington, Fred Hutchinson Cancer Research Center, University of Cape Town (UCT), Fred Hutchinson Cancer Research Center, National Institutes of Health, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, University of Washington - Department of Laboratory Medicine and Microbiology, Emory University - Division of Infectious Diseases, Emory University, Emory University, Federal University of Minas Gerais (UFMG), Fundación Huésped, Aurum Institute, Botswana Harvard AIDS Institute Partnership (BHP), University of Zimbabwe, University of Zimbabwe, Parirenyatwa Group of Hospitals, Hospital JM Ramos, Universidad Nacional de la Amazonía Peruana, The Aurum Institute, University of North Carolina (UNC) at Chapel Hill, Asociacion Civil Impacta Salud y Educacion, Universidad Nacional Mayor de San Marcos, Center for Family Health Research Zambia (CFHRZ), Ministry of Health Zambia - Zambia National Public Health Institute, MeCRU Clinical Research Site, Columbia University, Oswaldo Cruz Foundation (FIOCRUZ) - Instituto Nacional de Infectologia Evandro Chagas (INIEC), Oswaldo Cruz Foundation (FIOCRUZ) - Evandro Chagas National Institute of Infectious Diseases (INI), Aurum Institute, Setshaba Research Centre, Bio Analytical Research Corporation South Africa (BARC SA), University of Washington, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division and Fred Hutchinson Cancer Research Center
Downloads 39 (873,024)

Abstract:

Loading...

COVID-19, COVID, host demographics, viral shedding, viral load, CoVPN 5001

6.

Fixed Dosing Versus Weight-Based Dosing of HIV-1 Prophylactic Monoclonal Antibodies in Adults: A Pharmacokinetics Modeling Study

Number of pages: 23 Posted: 14 Jan 2025
Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Family Health International, HPTN Leadership and Operations Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Government of the United States of America - National Institute of Allergy and Infectious Diseases, Fred Hutchinson Cancer Research Center, Harvard University - Brigham and Women’s Hospital, University of North Carolina (UNC) at Chapel Hill - School of Medicine, Government of the United States of America - National Institute of Allergy and Infectious Diseases, Kelly Government Solutions, Columbia University - Aaron Diamond AIDS Research Center, Columbia University - Irving Medical Center, Emory University - School of Medicine, University of North Carolina (UNC) at Chapel Hill, Harvard University - Beth Israel Deaconess Medical Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Emory University - Division of Infectious Diseases, University of KwaZulu-Natal - Centre for the AIDS Programme of Research in South Africa (CAPRISA), George Washington University - School of Medicine and Health Sciences, National Institutes of Health, Government of the United States of America - National Institute of Allergy and Infectious Diseases, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of North Carolina (UNC) at Chapel Hill - Department of Medicine, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, National Institutes of Health - Vaccine Research Center and Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology
Downloads 35 (908,246)

Abstract:

Loading...

HIV prevention, dosing strategy, exponent of body weight, two-compartment, population pharmacokinetics model, variability in exposure

7.

Serum Concentration of Antigen-Specific IgG Can Bias Interpretation of the Readout of Antibody-Dependent Phagocytosis Assay

Number of pages: 20 Posted: 22 Dec 2022
Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division and Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division
Downloads 15 (1,127,477)

Abstract:

Loading...